Biotech · Private company
Claris Biotherapeutics, Inc.
Track this companyFree. Adds Claris Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CSB-001 Ophthalmic Solution 0.1%Phase 2 · Neurotrophic KeratitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle ControlPhase 2 · Neurotrophic KeratitisClinicalTrials.gov · fetched Nov 12, 2026
- CSB-001 Ophthalmic Solution 0.1%Phase 1 · Corneal ScarClinicalTrials.gov · fetched Nov 12, 2026
- CSB-001 Ophthalmic Solution 0.1%Phase 1 · Limbal Stem Cell DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Non-interventionalLimbal Stem Cell DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell DeficiencyRECRUITING · started May 22, 2026ClinicalTrials.gov NCT07636590 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell DeficiencyPHASE1 · RECRUITING · started May 15, 2024ClinicalTrials.gov NCT06452316 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal ScarsPHASE1 · RECRUITING · started Feb 5, 2024ClinicalTrials.gov NCT06257355 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis SubjectsPHASE1_PHASE2 · COMPLETED · started Aug 24, 2021ClinicalTrials.gov NCT04909450 · fetched Nov 12, 2026